BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Soriano A, Varona A, Gianchandani R, Moneva ME, Arranz J, Gonzalez A, Barrera M. Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World J Hepatol 2016; 8(1): 58-68 [PMID: 26783421 DOI: 10.4254/wjh.v8.i1.58]
URL: https://www.wjgnet.com/1007-9327/full/v8/i1/58.htm
Number Citing Articles
1
Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg, Allan Rasmussen. Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysisTransplantation Reviews 2016; 30(3): 171 doi: 10.1016/j.trre.2016.03.001
2
Lindsay A Sobotka, Alice Hinton, Lanla F Conteh. African Americans are less likely to receive curative treatment for hepatocellular carcinomaWorld Journal of Hepatology 2018; 10(11): 849-855 doi: 10.4254/wjh.v10.i11.849
3
Shao-cheng Lyu, Jing Wang, Zhang-yong Ren, Di Cao, Qiang He. Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria: A Single Center ExperienceCurrent Medical Science 2022; 42(3): 548 doi: 10.1007/s11596-022-2558-8
4
Gui-Qian Huang, Yao-Yao Xie, Pei-Wu Zhu, Xiao-Dong Wang, Zhuo Lin, Yan Wang, Jiang-Pin Ye, Yu-Min Wang, Ying-Xiao Chen, Xiao-Zhi Jin, Sven Van Poucke, Yong-Ping Chen, Ming-Hua Zheng. Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failureExpert Review of Gastroenterology & Hepatology 2018; 12(3): 295 doi: 10.1080/17474124.2018.1424540
5
Ju-Shan Wu, Ji-Liang Feng, Rui-Dong Zhu, San-Guang Liu, Da-Wei Zhao, Ning Li. Histopathological characteristics of needle core biopsy and surgical specimens from patients with solitary hepatocellular carcinoma or intrahepatic cholangiocarcinomaWorld Journal of Gastrointestinal Oncology 2019; 11(5): 404-415 doi: 10.4251/wjgo.v11.i5.404
6
Wong Hoi She, Albert Chi Yan Chan, Tan To Cheung, Chung Mau Lo, Kenneth Siu Ho Chok. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levelsWorld Journal of Hepatology 2018; 10(2): 308-318 doi: 10.4254/wjh.v10.i2.308
7
André C. Teixeira, Ivelise R.C. Brasil, Alba F.C. Torres, Fabio Tavora. The Evaluation of Angiogenesis Markers in Hepatocellular Carcinoma and Precursor Lesions in Liver Explants From a Single InstitutionApplied Immunohistochemistry & Molecular Morphology 2018; 26(5): 330 doi: 10.1097/PAI.0000000000000426
8
Thomas M. Leventhal, Ellen Florek, Srinath Chinnakotla. Changes in liver allocation in United StatesCurrent Opinion in Organ Transplantation 2020; 25(1): 52 doi: 10.1097/MOT.0000000000000726
9
Zhicheng Liu, Dingquan Yang, Yanqing Li, Yan Jiao, Guangchao Lv. HN1 as a diagnostic and prognostic biomarker for liver cancerBioscience Reports 2020; 40(7) doi: 10.1042/BSR20200316
10
Chun Han Nigel Tan, Yue Yu, Yan Rui Nicholas Tan, Boon Leng Kieron Lim, Shridhar Ganpathi Iyer, Krishnakumar Madhavan, Alfred Wei Chieh Kow. Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?Annals of Hepato-Biliary-Pancreatic Surgery 2018; 22(1): 27 doi: 10.14701/ahbps.2018.22.1.27
11
Anjana Pillai, Thomas Couri, Michael Charlton. Liver Allocation Policies in the USA: Past, Present, and the FutureDigestive Diseases and Sciences 2019; 64(4): 985 doi: 10.1007/s10620-019-05549-y
12
Emily Harding‐Theobald, Francis Y.K. Yao, Neil Mehta. Neutrophil‐to‐Lymphocyte Ratio Predicts High‐Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular CarcinomaLiver Transplantation 2021; 27(6): 818 doi: 10.1002/lt.26010
13
Xiao-Qin He, Yue-Feng Zhang, Jia-Jun Yu, Yuan-Yuan Gan, Na-Na Han, Mei-Xia Zhang, Wei Ge, Jun-Jian Deng, Yong-Fa Zheng, Xi-Ming Xu. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathwayTumor Biology 2017; 39(3): 101042831769597 doi: 10.1177/1010428317695971
14
Aline Lopes CHAGAS, Angelo Alves de MATTOS, Flair José CARRILHO, Paulo Lisboa BITTENCOURT, Denise Cerqueira Paranaguá VEZOZZO, Natally HORVAT, Manoel de Souza ROCHA, Venâncio Avancini Ferreira ALVES, Gabriela Perdomo CORAL, Mario Reis ALVARES-DA-SILVA, Fabio Marinho do Rego BARROS, Marcos Roberto MENEZES, Lucas Moretti MONSIGNORE, Fabricio Ferreira COELHO, Renato Ferreira da SILVA, Rita de Cássia Martins Alves SILVA, Ilka de Fatima Santana Ferreira BOIN, Luiz Augusto Carneiro D`ALBUQUERQUE, José Huygens Parente GARCIA, Guilherme Eduardo Gonçalves FELGA, Airton Mota MOREIRA, Maria Ignez Freitas Melro BRAGHIROLI, Paulo Marcelo Gehm HOFF, Vivianne Barretto de MELLO, Mariana Fonseca DOTTORI, Tiago Pugliese BRANCO, Leonardo de Lucca SCHIAVON, Thaisa de Fátima Almeida COSTA. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMAArquivos de Gastroenterologia 2020; 57(suppl 1): 1 doi: 10.1590/s0004-2803.202000000-20
15
Kim M. Olthoff, David S. Goldberg. The MoRAL Path Beyond MilanAnnals of Surgery 2016; 263(5): 851 doi: 10.1097/SLA.0000000000001679
16
Edison Moraes Rodrigues-Filho, Cristiano Augusto Franke, José Roque Junges. Transplante de fígado e alocação dos órgãos no Brasil: entre Rawls e o utilitarismoCadernos de Saúde Pública 2018; 34(11) doi: 10.1590/0102-311x00155817
17
Christian P. Strassburg. HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?Visceral Medicine 2016; 32(4): 263 doi: 10.1159/000446385